APA (7th ed.) Citation

Sinha, A., Ghosh, A., Ghosh, A., Mathai, S., Bhaumik, J., Mukhopadhyay, A., . . . Sengupta, S. (2024). MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2. Clinical Epigenetics, 16(1), 1. https://doi.org/10.1186/s13148-024-01651-9

Chicago Style (17th ed.) Citation

Sinha, Abarna, Abhisikta Ghosh, Arnab Ghosh, Sonia Mathai, Jaydip Bhaumik, Asima Mukhopadhyay, Arindam Maitra, Nidhan K. Biswas, and Sharmila Sengupta. "MAL Expression Downregulation Through Suppressive H3K27me3 Marks at the Promoter in HPV16-related Cervical Cancers Is Prognostically Relevant and Manifested by the Interplay of Novel MAL Antisense Long Noncoding RNA AC103563.8, E7 Oncoprotein and EZH2." Clinical Epigenetics 16, no. 1 (2024): 1. https://doi.org/10.1186/s13148-024-01651-9.

MLA (9th ed.) Citation

Sinha, Abarna, et al. "MAL Expression Downregulation Through Suppressive H3K27me3 Marks at the Promoter in HPV16-related Cervical Cancers Is Prognostically Relevant and Manifested by the Interplay of Novel MAL Antisense Long Noncoding RNA AC103563.8, E7 Oncoprotein and EZH2." Clinical Epigenetics, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13148-024-01651-9.